Get the Stockscreener App
13.48
5.89%
+0.75
Adlai Nortye Ltd. ADR stock is currently priced at $13.48, with a 24-hour trading volume of 834.
It has seen a +5.89% increased in the last 24 hours and a +62.68% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $13.07 pivot point. If it approaches the $14.20 resistance level, significant changes may occur.
Previous Close:
$12.73
Open:
$13
24h Volume:
834
Market Cap:
$497.42M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-5.3498
EPS:
-2.5197
Net Cash Flow:
-
1W Performance:
-2.32%
1M Performance:
+62.68%
6M Performance:
+56.74%
1Y Performance:
+0.00%
1D Range:
$13.00
$13.48
52W Range:
$7.1114
$19.30
Adlai Nortye Ltd. ADR Stock (ANL) Company Profile
Name
Adlai Nortye Ltd. ADR
Sector
Industry
Phone
848 230 7430
Address
PO Box 309, Ugland House Grand Cayman
Adlai Nortye Ltd. ADR Stock (ANL) Latest News
Is Adlai Nortye Ltd. Sponsored ADR (ANL) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Model N, Ducommun, Perpetua Resources And Other Big Stocks Moving Higher On Monday
Benzinga
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire Inc.
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Adlai Nortye Ltd. ADR Stock (ANL) Financials Data
There is no financial data for Adlai Nortye Ltd. ADR (ANL). Check out other stocks for more information.
About Adlai Nortye Ltd. ADR
Adlai Nortye is a biotech company that is developing new cancer drugs. They are focused on finding cures for cancer and making it a chronic disease that can be managed. Adlai Nortye has several drug candidates in clinical trials, and they are working with other big pharmaceutical companies to bring these drugs to market around the world. In other words, Adlai Nortye is a company that is working to make cancer a treatable disease. They are developing new drugs and working with other companies to make sure that these drugs are available to patients around the world.
0.58%
1.18%
Cap:
|
Volume (24h):